www.veracyte.com
Open in
urlscan Pro
141.193.213.21
Public Scan
Submitted URL: https://veracyte-services.com/
Effective URL: https://www.veracyte.com/
Submission: On October 24 via automatic, source certstream-suspicious — Scanned from DE
Effective URL: https://www.veracyte.com/
Submission: On October 24 via automatic, source certstream-suspicious — Scanned from DE
Form analysis
0 forms found in the DOMText Content
* Tests * Diseases areas * Cancer * Thyroid cancer * Prostate cancer * Lung cancer * Breast cancer * Bladder cancer * Other * Interstitial lung disease Portfolio and test expansion * Products * Thyroid Cancer Afirma Genomic Sequencing Classifier * Prostate Cancer Decipher Prostate Genomic Classifier * Breast Cancer Prosigna Breast Cancer Assay * Interstitial Lung Disease Envisia Genomic Classifier * Bladder Cancer Decipher Bladder Genomic Classifier * Instructions for use * Quality certificates * Safety data sheets Enabling global access * Pipeline * Portfolio and test expansion * Enabling global access * MRD technology * Publications * Partner Services * Biopharma services * IVD services * Company * About us * Who we are * Leadership * Corporate recognition Culture * Contact * News & Events * News * Press releases * In the news Who we are * Events * Careers * Culture * Job openings * Investors * Overview * Press Releases * Events & Presentations * Financials * SEC filings * Quarterly results * Annual reports * Stock information * Analyst coverage ESG information * Governance * Governance overview * Board of directors * Committee Composition * Leadership * ESG information Annual reports * Investor Resources * Investor FAQs * Information request * Email alerts Annual reports AT VERACYTE WE BELIEVE EXCEPTIONAL CANCER CARE BEGINS WITH EXCEPTIONAL DIAGNOSTICS. Who we are NEWS UPDATE C2i Genomics is now a part of Veracyte Press release VERACYTE’S MOLECULAR TESTS EMPOWER CLINICIANS WITH THE HIGH-VALUE INSIGHTS THEY NEED IN THE RACE TO DIAGNOSE AND TREAT CANCER. THYROID CANCER Afirma® Genomic Sequencing Classifier PROSTATE CANCER Decipher® Prostate Genomic Classifier BREAST CANCER Prosigna® Breast Cancer Assay ILD Envisia® Genomic Classifier Bladder Cancer Decipher® Bladder Genomic Classifier PROVIDING HIGH-VALUE INSIGHTS CLINICIANS AND PATIENTS MAY STRUGGLE WITH UNCERTAINTY DURING CANCER DIAGNOSIS AND TREATMENT DECISION-MAKING. OUR TESTS CAN HELP THEM MOVE FORWARD WITH CONFIDENCE. Portfolio and test expansion TESTS THAT HELP CLINICIANS GUIDE AND ASSURE PATIENTS AT PIVOTAL MOMENTS There are pivotal moments in a patient’s cancer care journey where key decisions can impact the patient’s pathway and outcome. Whether diagnosing suspicious symptoms or determining treatment next steps, deciding on the best path forward can be a challenging and uncertain endeavor without the right data. Veracyte’s tests provide answers that enable clinicians and their patients to make more informed and confident decisions. Our diagnostic and prognostic tests provide clarity for some of the most complex diseases, helping patients avoid unnecessary procedures and speeding time to appropriate diagnosis and treatment. ELEVATING THE STANDARD OF CARE FOR TOMORROW Understanding cancer at the molecular level enables more personalized approaches to diagnosis and treatment. Veracyte’s tests deliver actionable insights rooted in both the known and the novel. OUR proven framework VERACYTE’S APPROACH TO DIAGNOSTICS We collaborate closely with clinicians and scientists to identify unmet needs that stand in the way of better care. And then, we find the answers. Our rigorous process enables more confident decision-making for clinicians, giving patients access to a higher standard of care. WE SEEK TO MAKE LEADING DIAGNOSTICS ACCESSIBLE TO PATIENTS ALL OVER THE WORLD. 400K The number of patients our tests have benefited.1 >7M The number of people globally each year who are diagnosed with a cancer that our tests address.2-4 1 IDENTIFY CLINICAL UNMET NEEDS We work with clinicians and scientists to develop our tests. Through a rigorous multi-disciplinary innovation process we identify unmet needs and create solutions that make clinicians’ and patients’ lives easier. 2 DEVELOP HIGH-PERFORMANCE TESTS We take a rigorous approach to ensuring product performance and utility, building evidence across a broad range of studies. Clinicians and patients need high-quality, reliable results they can trust. 3 RAMP PATIENT TESTING GLOBALLY We make our leading diagnostics widely available through a flexible CLIA- and in vitro diagnostic (IVD)-based model. We supplement this with our proven ability to build clinical evidence that drives reimbursement, encourages clinician adoption, and prompts guideline inclusion for our tests. ESG REPORT Veracyte’s Environmental, Social and Governance (ESG) Report sets the foundation for our ESG performance and articulates our ambitions to build a more sustainable, equitable future. ESG Report MAKING OUR TESTS AVAILABLE WORLDWIDE Through our centralized CLIA lab-based approach in the US and our growing menu of distributed IVDs to serve global markets, we aim to transform cancer care for patients all over the world. Enabling global access JOIN OUR TEAM Veracyte offers fulfilling career opportunities for curious, driven, and patient-oriented people who are inspired to find answers to some of the most challenging questions in medicine. Join us. Working at Veracyte REFERENCES 1. Company data on file. 2. Cancer. World Health Organization. Published February 3, 2022. Accessed July 19, 2023. https://www.who.int/news-room/fact-sheets/detail/cancer 3. Thyroid Cancer – Statistics. Cancer.Net. Accessed July 19, 2023. https://www.cancer.net/cancer-types/thyroid-cancer/statistics 4. Bladder Cancer. International Agency for Research on Cancer. Accessed July 19, 2023. https://www.iarc.who.int/cancer-type/bladder-cancer/ © 2024 Veracyte, Inc. All rights reserved. OFFICES * SOUTH SAN FRANCISCO, CA 6000 Shoreline Court, Suite 300 South San Francisco, CA 94080 United States * MARSEILLE, FRANCE 163 Avenue de Luminy Marseille 13009 FRANCE * SAN DIEGO, CA 6925 Lusk Boulevard, Suite 200 San Diego, CA 92121 United States * AUSTIN, TX 12357-A Riata Trace Parkway Building 5, Suite 100 Austin, TX 78727 United States * HAIFA, ISRAEL Nahum Het 7 Haifa, Israel 3508506 ISRAEL HELPFUL LINKS * Privacy information center * Terms of Use * Terms of Sale * No Surprises Act * Business ethics and compliance * Accessibility * Cookies Settings CONNECT * Contact * LinkedIn * X (Twitter) * YouTube This website uses cookies to measure and analyze website performance and usage, enhance user experiences, personalize content and ads, and provide social media and other third party features. By clicking "Accept All Cookies", you are directing Veracyte to disclose information that may be considered personal information to third parties for these purposes. You may click the "Reject All" button to reject all cookies except those that are necessary for the website to function and cannot be switched off in our system. You may also Additional information about the cookies this website uses is available in our Cookies Settings. Cookies Settings Reject All Accept All Cookies COOKIE PREFERENCE CENTER When you visit our website, we store cookies on your browser to collect information which is used to measure and analyze website performance and usage, enhance user experiences, personalize content and ads, and provide social media and other third-party features. You can choose to opt out of all third-party cookies on our website, other than those that are “necessary”, by turning off the category below; however, this may impact the functionality of the website. Click on the different category headings to find out more and to change settings. More information Allow All MANAGE CONSENT PREFERENCES STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for our website to function properly and cannot be switched off in our systems. Without these cookies, we cannot respond to your requests or provide you with the services you request or access on our website. For example, we use these cookies to do the following: to remember information you have entered on forms during a web browser session; for security purposes; and to route users to specific applications or specific servers. You can set your browser to block or alert you about these cookies, but if you do so, some parts of our website will not function properly. Cookies Details PERFORMANCE COOKIES Performance Cookies These cookies collect information about how you use our website - e.g. which pages you visit and if you experience any errors. They allow us to count visits and traffic sources so we can measure and improve the performance of our website. For example, they help us to know which pages are the most and least popular and see how visitors move around the site. Some of our performance cookies are managed for us by third parties. If you do not allow these cookies we will not know when you have visited our site and will not be able to monitor its performance. Where required by law, we will obtain your consent before placing these cookies. Cookies Details TARGETING COOKIES Targeting Cookies These are third-party cookies that allow us to better reach you with relevant ads and content—both on our website and on third-party websites, apps and online services—and to measure and improve our advertising and marketing. These cookies enable third-party ad companies to track your visits to our website, as well as other websites, apps and online services, which they use to understand your interests and activities in order to provide you more relevant ads on behalf of us and other companies. If you do not allow these cookies, you will still see ads online. Where required by law, we will obtain your consent before placing these cookies. Cookies Details Back Button COOKIE LIST Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label Reject All Confirm My Choices